China Opportunity Translation and Project Lead
AbbVie
China Opportunity Translation and Project Lead
AbbVie
Global biopharmaceutical company developing medicines
The Biotherapeutics and Genetic Medicine (BGM) team at AbbVie is a critical discovery engine enabling our ambition to become the top biopharma company in the world. We combine our best-in-class internal technical platforms with the rapidly growing scientific ecosystem in China to deliver transformational large-molecule clinical development candidates to patients at unparalleled speed.
We are seeking a strategic, scientifically grounded leader to report to the Director of China Strategy, BGM. This role will translate China opportunities into clear strategic, scientific, and operational recommendations; help land and progress early discovery projects in China; and strengthen connectivity between BGM China and global stakeholders. The position will coordinate closely with Venture, CEI, Development Sciences China, Development Sciences Global, Therapeutic Area teams, and other relevant global functions.
Responsibilities:
Lead projects primarily executed in China using academic, CRO, biotech, or other external R&D resources, while maintaining close alignment with Global BGM/Discovery and Development Sciences.
AbbVie is an equal opportunity employer and is committed to operating with integrity, driving innovation, transforming lives and serving our community. Equal Opportunity Employer/Veterans/Disabled.
US & Puerto Rico only - to learn more, visit https://www.abbvie.com/join-us/equal-employment-opportunity-employer.html
US & Puerto Rico applicants seeking a reasonable accommodation, click here to learn more:
https://www.abbvie.com/join-us/reasonable-accommodations.html
AbbVie is a global biopharmaceutical company that develops and sells medicines to treat serious health conditions. Its portfolio spans immunology, oncology, virology, neuroscience, and aesthetics, with products designed to modulate the immune system, target disease pathways, or support medical aesthetics. AbbVie compounds its products through a heavy emphasis on research and development, investing billions to build a steady pipeline of new therapies. Its medicines are brought to market by selling to healthcare providers, hospitals, and clinics, and in some cases directly to patients via prescriptions. The company differentiates itself through a wide, globally distributed product line, substantial R&D investment, and a commitment to sustainability and patient care, including science-based targets. AbbVie’s goal is to improve patient outcomes by delivering effective treatments for unmet medical needs while pursuing long-term, responsible growth across healthcare markets.
Explore more opportunities at AbbVie